Work

Functional Properties of Exon 17 KIT Mutations in Pediatric CBF AML Predict for Inferior Outcome and Enhanced Response to Tyrosine Kinase Inhibition: A Report from the Children's Oncology Group

Year: 2017

Type: article

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.25.25

Authors: Katherine Tarlock, Todd A. Alonzo, Robert B. Gerbing, Yi‐Cheng Wang, Rhonda E. Ries, Tiffany Hylkema, Jason Joaquin, Susana C. Raimondi, Betsy Hirsch, E. Anders Kolb, Alan S. Gamis, Soheil Meshinchi, Jessica A. Pollard

Institutions: Seattle Children's Hospital, Fred Hutch Cancer Center, University of Southern California, Children's Oncology Group, St. Jude Children's Research Hospital, University of Minnesota, Alfred I. duPont Hospital for Children, Children's Mercy Hospital, University of Washington, Tufts University, Maine Medical Center, Maine Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3153199788

FWCI: 0.362

Cites:

Cited by: 2

Related to: 20